Table: Taiko Pharmaceutical -Q1 group results

Taiko Pharmaceutical

12/08/2020 07:00

Aug 12 (Reuters)- 
             Taiko Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended      9 months to 
                  Jun 30, 2020        Jun 30, 2019       Dec 31, 2020  
                     LATEST             YEAR-AGO            LATEST     
                     RESULTS             RESULTS           FORECAST    
  Sales               5.77                1.42              18.00      
                                       (+11.9 pct)                     
  Operating           2.76               180 mln             5.50      
                                      (+193.0 pct)                     
  Recurring           2.70               127 mln             5.30      
                                      (+347.2 pct)                     
  Net                 1.87               103 mln             3.80      
                                      (+165.8 pct)                     
  EPS               43.56 yen           2.41 yen          88.49 yen    
  EPS Diluted       43.28 yen           2.40 yen                       
  Ann Div                               50.00 yen         17.00 yen    
  -Q2 div                               10.00 yen          7.00 yen    
  -Q4 div                               40.00 yen         10.00 yen    
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T